Related Experiment Video
Updated: May 23, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
[Adults with cystic fibrosis. It's not just about longevity]
H von der Hardt1, C Schwarz, G Ullrich
1ehem. Medizinische Hochschule Hannover, Hannover, Deutschland.
Insights
Medical advances have significantly increased lifespan for individuals with cystic fibrosis (CF). However, this improved longevity brings challenges like long-term complications and treatment burdens, impacting quality of life.
Area of Science:
- Pulmonology and Genetic Medicine
- Chronic Disease Management
Context:
- Cystic Fibrosis (CF) management has evolved, shifting from a childhood disease to a chronic condition impacting adults.
- Since 2009, adults constitute the majority of CF patients in the German registry, highlighting increased longevity.
- Improved survival rates present new challenges, including long-term complications and treatment burdens.
Purpose:
- To discuss the evolving landscape of Cystic Fibrosis care.
- To address the long-term complications and treatment burdens associated with increased patient longevity.
- To emphasize the psychosocial aspects of prolonged life for CF patients.
Summary:
- Medical progress has dramatically improved longevity in Cystic Fibrosis patients.
- Long-term complications such as CF-related diabetes (CFRD) and osteoporosis are increasingly prevalent.
- The cumulative effects of decades-long treatments and the psychosocial impact of living longer with CF require careful consideration.
Impact:
- Highlights the need to balance treatment benefits against long-term side effects and burden.
- Underscores the importance of addressing the psychosocial challenges of extended survival in CF.
- Emphasizes that prolonged life in CF must be meaningful, not just longer.
Abstract:
Cystic fibrosis (CF) is one example of serious disorders for which medical progress and the integration of chronic treatment into the patients' daily routines have led to markedly better longevity. Formerly known as a 'killer disease' of childhood, CF is now considered a disorder with childhood onset, but is well known in adult medicine. Since 2009, for the first time CF adults have made up the majority of patients in the German CF registry. The drawbacks of improved longevity are long-term complications (e.g., CFRD, osteoporosis) that were rarely seen before. In particular, unwanted effects of treatments that today are performed for decades rather than years are becoming pressing problems. Unwanted effects as well as the ever-increasing treatment burden must be carefully weighed against the expected benefits of treatment. However, CF medicine has always been aware that it is not just about longevity, but that prolonged life has to have meaning. Therefore, the marked increase in longevity is also a psychosocial challenge. So far, empirical data suggest that the majority of people with CF courageously struggle for a normal life.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Longitudinal Research
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Development of Human Microbiota

